Heritage Pharmaceuticals opens new production facility in New Jersey

The 38,000-square-foot facility brings the total manufacturing area for Heritage to 125,000 square feet. (Heritage Pharmaceuticals)

Heritage Pharmaceuticals, based in East Brunswick, New Jersey, opened a new manufacturing facility that was built using modular cleanroom walls.

The 38,000-square-foot facility brings the total manufacturing area for Heritage to 125,000 square feet. The company expects to increase its total employee count at the site to 225 by early next year.

“We are very excited about this move, as it will enable us to consolidate three geographically separated offices into one ‘campus’ in East Brunswick, facilitating more efficient internal communication,” Scott Delaney, Heritage’s president, said in a statement.

Webinar

Striving for Zero in Quality & Manufacturing

Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. This on-demand webinar discusses the role that content management plays in pharmaceutical manufacturing to help companies reach the goal of zero in Quality and Manufacturing.

Heritage produces 28 products, including tablets, capsules, soft gels and powders for suspension, with an annualized volume of 2 billion units and packaging of 1.5 million serialized units. 

The new addition has already been approved by Health Canada, European Medicines agency and TGA Australia, the company said.

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.